跳至主要内容
临床试验/NCT02176109
NCT02176109Unknown不适用

Rôle Pronostique Des métabolismes du Stress Oxydatif et du Fer Dans Les Leucémies Aiguës Myéloblastiques

University Hospital, Grenoble1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2013年6月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
80
试验地点
1
主要终点
overall survival Event-free survival Response to induction chemotherapy, overalll survival, event-free survival

研究概览

简要总结

In this study, the investigators study the prognostic role of oxidative stress metabolism and iron in Acute myeloid leukemia.

详细描述

Primary goal of this study is to Evaluate the characteristics of regulatory networks of iron and redox balance in leukemic cells, to study the correlations between the prognosis of AML patients (in terms of response to induction chemotherapy and survival i) and metabolism of these markers. Secondary ones areto assess the impact of induction therapy on markers of oxidative stress and to correlate biological iron and redox metabolism with the molecular status of patients (eg Flt3/IDH/CEBPA/NPM...).

Eligibility criteria are patients at diagnostic of de novo acute myeloid leukemia (promyelocytic excluded) aged from 18 to 100 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • de novo acute myeloid leukemic patient from 18 years to 99 years at diagnosis

排除标准

  • age under 18 years promelocytic leukemia secondary leukemia

结局指标

主要结局

overall survival Event-free survival Response to induction chemotherapy, overalll survival, event-free survival

时间窗: five years after the inclusion

次要结局

未报告次要终点

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验